Publication Name	World Journal of Clinical Cases
Manuscript ID	62286
Country	Taiwan

Received	2021-01-04 16:14
Peer-Review Started	2021-01-04 16:16
First Decision by Editorial Office Director	2021-01-23 04:31
Return for Revision	2021-01-23 12:41
Revised	2021-02-05 19:09
Publication Fee Transferred
Second Decision by Editor	2021-03-25 12:41
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2021-03-26 04:14
Articles in Press	2021-03-26 04:14
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-04-01 01:40
Publish the Manuscript Online	2021-04-22 12:14

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives
Manuscript Source	Invited Manuscript
All Author List	Hung-Yuan Su and Yin-Chou Hsu
Funding Agency and Grant Number
Corresponding Author	Yin-Chou Hsu, MD, Staff Physician, Department of Emergency Medicine, E-DA Hospital, I-Shou University, No.1, Yida Road, Jiao-su Village, Yan-chao District , Kaohsiung 82445, Taiwan. yinchou0406@gmail.com
Key Words	COVID-19; SARS-CoV-2; Cirrhosis; Acute liver injury; Prognosis; Therapy
Core Tip	Several studies have addressed the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with cirrhosis. The presence and stage of cirrhosis is correlated with the development of severe coronavirus disease-2019 (COVID-19), COVID-19-related adverse outcomes, and mortality. It remains unclear whether SARS-CoV-2 infection is a trigger of acute decompensation or acute-on-chronic liver failure in cirrhotic patients based on the current evidence. There is still no clearly proven effective pharmacological treatment for cirrhotic patients with COVID-19. Clinicians should maintain standard cirrhosis care, defer unnecessary liver-specific procedures and have a low threshold for admission if cirrhotic patients are infected with SARS-CoV-2.
Publish Date	2021-04-22 12:14
Citation	Su HY, Hsu YC. Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives. World J Clin Cases 2021; 9(13): 2951-2968
URL	https://www.wjgnet.com/2307-8960/full/v9/i13/2951.htm
DOI	https://dx.doi.org/10.12998/wjcc.v9.i13.2951

Full Article (PDF)	WJCC-9-2951.pdf
Full Article (Word)	WJCC-9-2951.docx
Manuscript File	62286_Auto_Edited_LM.docx
Answering Reviewers	62286-Answering reviewers.pdf
Audio Core Tip	62286-Audio core tip.wav
Conflict-of-Interest Disclosure Form	62286-Conflict-of-interest statement.pdf
Copyright License Agreement	62286-Copyright license agreement.PDF
Non-Native Speakers of English Editing Certificate	62286-Language certificate.pdf
Peer-review Report	62286-Peer-review(s).pdf
Scientific Misconduct Check	62286-Bing-Ma YJ-1.jpg
Scientific Misconduct Check	62286-Bing-Liu M-2.jpg
Scientific Misconduct Check	62286-Scientific misconduct check.pdf
Scientific Editor Work List	62286-Scientific editor work list.pdf
CrossCheck Report	62286-CrossCheck report.pdf